메뉴 건너뛰기




Volumn 64, Issue 5-6, 1998, Pages 287-295

Estrogen- and antiestrogen-responsiveness of HEC1A endometrial adenocarcinoma cells in culture

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CATHEPSIN D; COMPLEMENT COMPONENT C3; CREATINE KINASE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; TAMOXIFEN;

EID: 0031922471     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00202-1     Document Type: Article
Times cited : (36)

References (57)
  • 2
    • 84959824962 scopus 로고
    • Stat bite. Top 5 cancers for females and males in the U.S
    • Fries L. A. G. Stat bite. Top 5 cancers for females and males in the U.S. J. Natl. Cancer Inst. 87:1995;867.
    • (1995) J. Natl. Cancer Inst. , vol.87 , pp. 867
    • Fries, L.A.G.1
  • 5
    • 0023709110 scopus 로고
    • Reproductive factors and risk of cancer of the uterine corpus: A prospective study
    • Kvale G., Heuch I., Ursin G. Reproductive factors and risk of cancer of the uterine corpus: A prospective study. Cancer Res. 48:1988;6217-6221.
    • (1988) Cancer Res. , vol.48 , pp. 6217-6221
    • Kvale, G.1    Heuch, I.2    Ursin, G.3
  • 7
    • 0023155215 scopus 로고
    • Combination oral contraceptive use and the risk of endometrial cancer
    • The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
    • Anonymous Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. JAMA. 257:1987;796-800.
    • (1987) JAMA , vol.257 , pp. 796-800
  • 10
    • 0023836871 scopus 로고
    • Estrogens as a cause of human cancer: The Richard and Hinda rosenthal foundation award lecture
    • Henderson B. E., Ross R., Bernstein L. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation award lecture. Cancer Res. 48:1988;246-253.
    • (1988) Cancer Res. , vol.48 , pp. 246-253
    • Henderson, B.E.1    Ross, R.2    Bernstein, L.3
  • 11
    • 0023857383 scopus 로고
    • The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
    • Key T. J. A., Pike M. C. The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer. 57:1988;205-212.
    • (1988) Br. J. Cancer , vol.57 , pp. 205-212
    • Key, T.J.A.1    Pike, M.C.2
  • 12
    • 0028287647 scopus 로고
    • Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
    • Kedar R. P., Bourne T. H., Powles T. J., Collins W. P., Ashley S. E., Cosgrove D. O., Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet. 343:1994;1318-1321.
    • (1994) Lancet , vol.343 , pp. 1318-1321
    • Kedar, R.P.1    Bourne, T.H.2    Powles, T.J.3    Collins, W.P.4    Ashley, S.E.5    Cosgrove, D.O.6    Campbell, S.7
  • 13
    • 0028208456 scopus 로고
    • Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the national surgical adjuvant breast and bowel project (NSABP) B-14
    • Fisher B., Costantino J. P., Redmond C. K., Fisher E. R., Wickerham D. L., Cronin W. M. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 86:1994;527-537.
    • (1994) J. Natl. Cancer Inst. , vol.86 , pp. 527-537
    • Fisher, B.1    Costantino, J.P.2    Redmond, C.K.3    Fisher, E.R.4    Wickerham, D.L.5    Cronin, W.M.6
  • 17
    • 0028840057 scopus 로고
    • When tamoxifen turns bad
    • Horwitz K. B. When tamoxifen turns bad. Endocrinology. 136:1995;821-823.
    • (1995) Endocrinology , vol.136 , pp. 821-823
    • Horwitz, K.B.1
  • 18
    • 0027942428 scopus 로고
    • Should clinicians be concerned about the carcinogenic potential of tamoxifen?
    • Jordan V. C., Morrow M. Should clinicians be concerned about the carcinogenic potential of tamoxifen? Eur. J. Cancer. 30A:1994;1714-1721.
    • (1994) Eur. J. Cancer , vol.30 A , pp. 1714-1721
    • Jordan, V.C.1    Morrow, M.2
  • 19
    • 0029012731 scopus 로고
    • Tamoxifen and the induction of cancer
    • King C. M. Tamoxifen and the induction of cancer. Carcinogenesis. 16:1995;1449-1454.
    • (1995) Carcinogenesis , vol.16 , pp. 1449-1454
    • King, C.M.1
  • 20
    • 0028936687 scopus 로고
    • Tamoxifen and tumorigenicity: A predictable concern
    • Jordan V. C. Tamoxifen and tumorigenicity: A predictable concern. J. Natl. Cancer Inst. 87:1995;623-625.
    • (1995) J. Natl. Cancer Inst. , vol.87 , pp. 623-625
    • Jordan, V.C.1
  • 21
    • 0015511738 scopus 로고
    • Establishment of a cell line of human endometrial adenocarcinoma in vitro
    • Kuramoto H., Tamura S., Notake Y. Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am. J. Obstet. Gynecol. 114:1972;1012-1019.
    • (1972) Am. J. Obstet. Gynecol. , vol.114 , pp. 1012-1019
    • Kuramoto, H.1    Tamura, S.2    Notake, Y.3
  • 22
    • 0022486153 scopus 로고
    • Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line)
    • Holinka C. F., Hata H., Kuramoto H., Gurpide E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res. 46:1986;2771-2774.
    • (1986) Cancer Res. , vol.46 , pp. 2771-2774
    • Holinka, C.F.1    Hata, H.2    Kuramoto, H.3    Gurpide, E.4
  • 23
    • 0022549453 scopus 로고
    • Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa)
    • Holinka C. F., Hata H., Kuramoto H. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J. Steroid Biochem. 24:1986;85-89.
    • (1986) J. Steroid Biochem. , vol.24 , pp. 85-89
    • Holinka, C.F.1    Hata, H.2    Kuramoto, H.3
  • 24
    • 0022891813 scopus 로고
    • Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line)
    • Holinka C. F., Hata H., Gravanis A., Kuramoto H., Gurpide E. Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line). J. Steroid Biochem. 25:1986;781-786.
    • (1986) J. Steroid Biochem. , vol.25 , pp. 781-786
    • Holinka, C.F.1    Hata, H.2    Gravanis, A.3    Kuramoto, H.4    Gurpide, E.5
  • 26
    • 0024393479 scopus 로고
    • Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions
    • Holinka C. F., Anzai Y., Hata H., Kimmel N., Kuramoto H., Gurpide E. Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions. Cancer Res. 49:1989;3297-3301.
    • (1989) Cancer Res. , vol.49 , pp. 3297-3301
    • Holinka, C.F.1    Anzai, Y.2    Hata, H.3    Kimmel, N.4    Kuramoto, H.5    Gurpide, E.6
  • 27
    • 0024505760 scopus 로고
    • Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line)
    • Anzai Y., Holinka C. F., Kuramoto H., Gurpide E. Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line). Cancer Res. 49:1989;2362-2365.
    • (1989) Cancer Res. , vol.49 , pp. 2362-2365
    • Anzai, Y.1    Holinka, C.F.2    Kuramoto, H.3    Gurpide, E.4
  • 28
    • 0025892130 scopus 로고
    • The effect of anti-estrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa)
    • Jamil A., Croxtall J. D., White J. O. The effect of anti-estrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa). J. Mol. Endocrinol. 6:1991;215-221.
    • (1991) J. Mol. Endocrinol. , vol.6 , pp. 215-221
    • Jamil, A.1    Croxtall, J.D.2    White, J.O.3
  • 29
    • 0028015623 scopus 로고
    • Insensitivity of cathepsin D gene to estradiol in endometrial cells is determined by the sequence of its estrogen responsive element
    • Miralles F., Gaudelet C., Cavailles V., Rochefort H., Augereau P. Insensitivity of cathepsin D gene to estradiol in endometrial cells is determined by the sequence of its estrogen responsive element. Biochem. Biophys. Res. Commun. 203:1994;711-718.
    • (1994) Biochem. Biophys. Res. Commun. , vol.203 , pp. 711-718
    • Miralles, F.1    Gaudelet, C.2    Cavailles, V.3    Rochefort, H.4    Augereau, P.5
  • 30
    • 0024456658 scopus 로고
    • Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells
    • Touitou I., Cavailles V., Garcia M., DeFrenne A., Rochefort H. Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol. Cell Endocrinol. 66:1989;231-238.
    • (1989) Mol. Cell Endocrinol. , vol.66 , pp. 231-238
    • Touitou, I.1    Cavailles, V.2    Garcia, M.3    DeFrenne, A.4    Rochefort, H.5
  • 31
    • 0022981169 scopus 로고
    • Processing and estrogen regulation of the 52 kDa protein inside MCF-7 breast cancer cells
    • Morisset M., Capony F., Rochefort H. Processing and estrogen regulation of the 52 kDa protein inside MCF-7 breast cancer cells. Endocrinology. 119:1986;2773-2782.
    • (1986) Endocrinology , vol.119 , pp. 2773-2782
    • Morisset, M.1    Capony, F.2    Rochefort, H.3
  • 32
    • 0023617244 scopus 로고
    • Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen regulated RNAs in human breast cancer cells
    • May F. E. B., Westley B. R. Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen regulated RNAs in human breast cancer cells. J. Biol. Chem. 262:1987;15894-15899.
    • (1987) J. Biol. Chem. , vol.262 , pp. 15894-15899
    • May, F.E.B.1    Westley, B.R.2
  • 33
    • 0023224243 scopus 로고
    • Estrogen regulates cathepsin D mRNA levels in estrogen responsive human breast cancer cells
    • Westley B. R., May F. E. B. Estrogen regulates cathepsin D mRNA levels in estrogen responsive human breast cancer cells. Nucleic Acids Res. 15:1987;3773-3780.
    • (1987) Nucleic Acids Res. , vol.15 , pp. 3773-3780
    • Westley, B.R.1    May, F.E.B.2
  • 34
    • 0023856239 scopus 로고
    • Estrogens and growth factors induce mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells
    • Cavailles V., Augereau P., Garcia M., Rochefort H. Estrogens and growth factors induce mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 16:1988;1903-1919.
    • (1988) Nucleic Acids Res. , vol.16 , pp. 1903-1919
    • Cavailles, V.1    Augereau, P.2    Garcia, M.3    Rochefort, H.4
  • 35
    • 0026747027 scopus 로고
    • Development of gel staining techniques for detecting the secretion of procathepsin D (52 kDa protein) in MCF-7 human breast cancer cells
    • Krishnan V., Narasimhan T. R., Safe S. Development of gel staining techniques for detecting the secretion of procathepsin D (52 kDa protein) in MCF-7 human breast cancer cells. Anal. Biochem. 204:1992;137-142.
    • (1992) Anal. Biochem. , vol.204 , pp. 137-142
    • Krishnan, V.1    Narasimhan, T.R.2    Safe, S.3
  • 36
    • 0028884592 scopus 로고
    • Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
    • Krishnan V., Porter W., Santostefano M., Wang X., Safe S. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15:1995;6710-6719.
    • (1995) Mol. Cell. Biol. , vol.15 , pp. 6710-6719
    • Krishnan, V.1    Porter, W.2    Santostefano, M.3    Wang, X.4    Safe, S.5
  • 37
    • 0030968191 scopus 로고    scopus 로고
    • Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs
    • Nodland K. I., Wormke M., Safe S. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs. Arch. Biochem. Biophys. 338:1997;67-72.
    • (1997) Arch. Biochem. Biophys. , vol.338 , pp. 67-72
    • Nodland, K.I.1    Wormke, M.2    Safe, S.3
  • 38
    • 0029118684 scopus 로고
    • Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
    • Safe S. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67:1995;247-281.
    • (1995) Pharmacol. Ther. , vol.67 , pp. 247-281
    • Safe, S.1
  • 39
    • 0025224762 scopus 로고
    • Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene
    • Hobson G. M., Molloy G. R., Benfield P. A. Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene. Mol. Cell. Biol. 10:1990;6533-6543.
    • (1990) Mol. Cell. Biol. , vol.10 , pp. 6533-6543
    • Hobson, G.M.1    Molloy, G.R.2    Benfield, P.A.3
  • 40
    • 0025238747 scopus 로고
    • The stimulation of uterine complement component C3 gene expression by antiestrogens
    • Sundstrom S. A., Komm B. S., Xu Q., Boundy V., Lyttle C. R. The stimulation of uterine complement component C3 gene expression by antiestrogens. Endocrinology. 126:1990;1449-1456.
    • (1990) Endocrinology , vol.126 , pp. 1449-1456
    • Sundstrom, S.A.1    Komm, B.S.2    Xu, Q.3    Boundy, V.4    Lyttle, C.R.5
  • 41
    • 84995870933 scopus 로고
    • Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
    • Tzukerman M. T., Esty A., Santiso-Mere D., Danielian P., Parker M. G., Stein R. G., Pike J. W., McDonnell D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
    • (1994) Mol. Endocrinol. , vol.8 , pp. 21-30
    • Tzukerman, M.T.1    Esty, A.2    Santiso-Mere, D.3    Danielian, P.4    Parker, M.G.5    Stein, R.G.6    Pike, J.W.7    McDonnell, D.P.8
  • 42
    • 0029038986 scopus 로고
    • Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
    • McDonnell D. P., Clemm D. L., Hermann T., Goldman M. E., Pike J. W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:1995;659-669.
    • (1995) Mol. Endocrinol. , vol.9 , pp. 659-669
    • McDonnell, D.P.1    Clemm, D.L.2    Hermann, T.3    Goldman, M.E.4    Pike, J.W.5
  • 43
    • 0029856633 scopus 로고    scopus 로고
    • Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity
    • Norris J. D., Fan D. J., Wagner B. L., McDonnell D. P. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol. Endocrinol. 10:1996;1605-1616.
    • (1996) Mol. Endocrinol. , vol.10 , pp. 1605-1616
    • Norris, J.D.1    Fan, D.J.2    Wagner, B.L.3    McDonnell, D.P.4
  • 44
    • 0023284318 scopus 로고
    • Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma
    • Dickson R. B., Lippman M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev. 8:1987;29-43.
    • (1987) Endocrine Rev. , vol.8 , pp. 29-43
    • Dickson, R.B.1    Lippman, M.E.2
  • 45
    • 0022842227 scopus 로고
    • Hormonal control of human breast cancer cell lines
    • Dickson R. B., Lippman M. E. Hormonal control of human breast cancer cell lines. Cancer Surveys. 5:1986;617-624.
    • (1986) Cancer Surveys , vol.5 , pp. 617-624
    • Dickson, R.B.1    Lippman, M.E.2
  • 46
    • 0024377283 scopus 로고
    • Mechanisms of growth control in normal and malignant breast epithelium
    • Lippman M. E., Dickson R. B. Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog. Hormone Res. 45:1989;383-440.
    • (1989) Recent Prog. Hormone Res. , vol.45 , pp. 383-440
    • Lippman, M.E.1    Dickson, R.B.2
  • 47
    • 0028099302 scopus 로고
    • Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line
    • Hana V., Murphy L. J. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line. Endocrinology. 135:1994;2511-2516.
    • (1994) Endocrinology , vol.135 , pp. 2511-2516
    • Hana, V.1    Murphy, L.J.2
  • 48
    • 0026763957 scopus 로고
    • Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells
    • Gong Y., Ballejo G., Murphy L. C., Murphy L. J. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res. 52:1992;1704-1709.
    • (1992) Cancer Res. , vol.52 , pp. 1704-1709
    • Gong, Y.1    Ballejo, G.2    Murphy, L.C.3    Murphy, L.J.4
  • 49
    • 0026756867 scopus 로고
    • MCDF, 6-methyl-1,3,8-trichlorodibenzofuran
    • Safe S. MCDF, 6-methyl-1,3,8-trichlorodibenzofuran. Drugs Future. 17:1992;564-565.
    • (1992) Drugs Future , vol.17 , pp. 564-565
    • Safe, S.1
  • 50
    • 0029655360 scopus 로고    scopus 로고
    • Estrogen activates migration potential of endometrial cancer cells through basement membrane
    • Fujimoto J., Hori M., Ichigo S., Morishita S., Tamaya T. Estrogen activates migration potential of endometrial cancer cells through basement membrane. Tumour. Biol. 17:1996;48-57.
    • (1996) Tumour. Biol. , vol.17 , pp. 48-57
    • Fujimoto, J.1    Hori, M.2    Ichigo, S.3    Morishita, S.4    Tamaya, T.5
  • 52
    • 0021709492 scopus 로고
    • Biochemical pharmacology of antiestrogen action
    • Jordan V. C. Biochemical pharmacology of antiestrogen action. Pharmacol. Rev. 36:1984;245-270.
    • (1984) Pharmacol. Rev. , vol.36 , pp. 245-270
    • Jordan, V.C.1
  • 53
    • 8044231949 scopus 로고    scopus 로고
    • Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells and yeast-based estrogen receptor assays: No apparent synergism
    • Ramamoorthy K., Wang F., Chen I.-C., Norris J. D., McDonnell D. P., Gaido K. W., Bocchinfuso W. P., Korach K. S., Safe S. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells and yeast-based estrogen receptor assays: No apparent synergism. Endocrinology. 138:1997;1520-1527.
    • (1997) Endocrinology , vol.138 , pp. 1520-1527
    • Ramamoorthy, K.1    Wang, F.2    Chen, I.-C.3    Norris, J.D.4    McDonnell, D.P.5    Gaido, K.W.6    Bocchinfuso, W.P.7    Korach, K.S.8    Safe, S.9
  • 55
    • 0031039888 scopus 로고    scopus 로고
    • Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
    • Kuiper G. G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
    • (1997) Endocrinology , vol.138 , pp. 863-870
    • Kuiper, G.G.1    Carlsson, B.2    Grandien, K.3    Enmark, E.4    Häggblad, J.5    Nilsson, S.6    Gustafsson, J.A.7
  • 56
    • 0031561119 scopus 로고    scopus 로고
    • Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: Functional difference between estrogen receptors α and β
    • Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: Functional difference between estrogen receptors α and β Biochem. Biophys. Res. Commun. 236:1997;140-145.
    • (1997) Biochem. Biophys. Res. Commun. , vol.236 , pp. 140-145
    • Watanabe, T.1    Inoue, S.2    Ogawa, S.3    Ishii, Y.4    Hiroi, H.5    Ikeda, K.6    Orimo, A.7    Muramatsu, M.8
  • 57
    • 0030071445 scopus 로고    scopus 로고
    • Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
    • Katzenellenbogen J. A., O'Malley B. W., Katzenellenbogen B. S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:1996;119-131.
    • (1996) Mol. Endocrinol. , vol.10 , pp. 119-131
    • Katzenellenbogen, J.A.1    O'Malley, B.W.2    Katzenellenbogen, B.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.